Stock DSGN DESIGN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Design Therapeutics, Inc.

Equities

DSGN

US25056L1035

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
3.31 USD -1.49% Intraday chart for Design Therapeutics, Inc. -6.50% +24.91%
06-17 Design Therapeutics, Inc. Elects Pratik Shah, Ph.D. as Class III Director CI
05-08 Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DESIGN THERAPEUTICS, INC. Stock Design Therapeutics, Inc.
 187M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 52.73B -
LONZA GROUP AG Stock Lonza Group AG
 39B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.38B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.39B
  1. Stock Market
  2. Equities
  3. DSGN Stock
  4. Charts Design Therapeutics, Inc.
  5. Sector Chart